David Spaight

David Spaight currently works at CellCarta Biosciences, Inc., as Chairman, HistoGenex Holding NV, as Director from 2019, and Certara, Inc., as Independent Director from 2022.
Mr. Spaight also formerly worked at WIL Research Holding Co., Inc., as Chief Executive Officer, Charles River Laboratories Ashland LLC, as Chairman & Chief Executive Officer, BioIVT LLC, as Chairman, Association of Clinical Research Organizations, as Chairman, Accumen, Inc., as Executive Chairman, Oncology Analytics, Inc., as Executive Chairman, Revvity, Inc., as Vice President-Global Sales & Marketing in 2005, MDS Pharma Services (Canada), as President, Fisher Scientific Canada, as Vice President-Global Sales & Marketing, and PerkinElmer U.S.
LLC, as Vice President.
Mr. Spaight received his undergraduate degree and Masters Business Admin degree from the University of Michigan.